日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Maternal and Neonatal Outcomes Associated With Cesarean Versus Vaginal Delivery in the United States: A Population-Based Retrospective Cross-Sectional Analysis of CDC Natality Public Use Data (2017-2020)

美国剖宫产与阴道分娩相关的母婴结局：基于美国疾病控制与预防中心出生公共使用数据（2017-2020 年）的人群回顾性横断面分析

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.105143
Isikwei, Emasenyie; Igetei, Joseph E; Asade, Oluwatobi O; Ebere-Bank, Delete; Asamoah-Twum, Anita S; Oladimeji, Akinyele; Oyelese, Iyiola A; Okobi, Okelue E
发表日期：2026
文献求助 收藏

Early Versus Delayed Norepinephrine Initiation in Septic Shock: A Systematic Review and Meta-Analysis of Randomized and Observational Studies

脓毒性休克早期与延迟应用去甲肾上腺素的疗效比较：随机对照试验和观察性研究的系统评价和荟萃分析

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.98694
Manafa, Chibuzo C; Ekor, Oluwayemisi E; Akinboboye, Akintunde C; Okobi, Okelue E; Ojukwu, Gift; Ugbo, Osemwegie O; Mochu, Michael U; Isikwei, Emasenyie; Hernandez Borges, Sergio; Diaz-Miret, Miguel
毒理研究
免疫/内分泌
发表日期：2025
文献求助 收藏

Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615)

NEDD8 激活酶抑制剂 pevonedistat 与化疗联合治疗复发性或难治性实体瘤患儿的 1 期研究 (ADVL1615)

期刊:European Journal of Cancer
影响因子:7.1
doi:10.1016/j.ejca.2024.114241
Foster, Jennifer H; Reid, Joel M; Minard, Charles; Woodfield, Sarah; Denic, Kristina Z; Isikwei, Emasenyie; Voss, Stephan D; Nelson, Marvin; Liu, Xiaowei; Berg, Stacey L; Fox, Elizabeth; Weigel, Brenda J
发表日期：2024
文献求助 收藏

A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors

一项采用药代动力学终点的 1 期试验，旨在确定雷莫芦单抗治疗复发或难治性实体瘤（包括中枢神经系统肿瘤）儿童和青少年患者的最佳剂量。

期刊:Pediatric Blood & Cancer
影响因子:2.3
doi:10.1002/pbc.30817
Pilbeam, Kristy L; Pradhan, Kamnesh; Croop, James; Minard, Charles G; Liu, Xiaowei; Voss, Stephan D; Isikwei, Emasenyie; Berg, Stacey L; Reid, Joel M; Fox, Elizabeth; Weigel, Brenda J
肿瘤
肿瘤免疫
神经科学
发表日期：2024
文献求助 收藏

Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712

pevonedistat联合阿扎胞苷、氟达拉滨、阿糖胞苷治疗儿童复发/难治性AML的可行性：COG ADVL1712研究结果

期刊:Pediatric Blood & Cancer
影响因子:2.3
doi:10.1002/pbc.30672
Tarlock, Katherine; Liu, Xiaowei; Minard, Charles G; Isikwei, Emasenyie A; Reid, Joel M; Horton, Terzah M; Fox, Elizabeth; Weigel, Brenda J; Cooper, Todd
发表日期：2023
文献求助 收藏

FDA Approval Summary: Cabozantinib for Differentiated Thyroid Cancer

FDA批准摘要：卡博替尼用于治疗分化型甲状腺癌

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-0873
Duke, Elizabeth S; Barone, Amy K; Chatterjee, Somak; Mishra-Kalyani, Pallavi S; Shen, Yuan-Li; Isikwei, Emasenyie; Zhao, Hong; Bi, Youwei; Liu, Jiang; Rahman, Nam Atiqur; Wearne, Emily; Leighton, John K; Stephenson, Maritsa; Ojofeitimi, Idara; Scepura, Barbara; Nair, Abhilasha; Pazdur, Richard; Beaver, Julia A; Singh, Harpreet
甲状腺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2022
文献求助 收藏

A Phase I/II Trial of Nivolumab plus Ipilimumab in Children and Young Adults with Relapsed/Refractory Solid Tumors: A Children's Oncology Group Study ADVL1412

一项针对复发/难治性实体瘤儿童和青少年患者的纳武利尤单抗联合伊匹木单抗的 I/II 期试验：儿童肿瘤协作组研究 ADVL1412

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-2164
Davis, Kara L; Fox, Elizabeth; Isikwei, Emasenyie; Reid, Joel M; Liu, Xiaowei; Minard, Charles G; Voss, Stephan; Berg, Stacey L; Weigel, Brenda J; Mackall, Crystal L
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏